Biosimilar medicine fact sheet – pegfilgrastim

This fact sheet provides information about biosimilar brands of pegfilgrastim listed on the Pharmaceutical Benefits Scheme (PBS).

  • Ziextenzo® was listed on the PBS on 1 March 2020.
  • Pelgraz® was listed on the PBS on 1 August 2020.

These brands are listed under the Section 100 IVF Highly Specialised Drugs Program.

Biosimilar medicine fact sheet – pegfilgrastim

About this resource

Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Tags: 

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.